← Open Payments lookup

MICHAEL LITTNER: Open Payments

NPI 1184071649 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,823 in 191 payments from 21 companies in 2025. Trend: 2023 $395 · 2024 $2,801 · 2025 $3,823

Food & beverage: $3,823
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$715
ABBVIE INC.22$500
Lundbeck LLC24$370
Otsuka America Pharmaceutical, Inc.19$355
Teva Pharmaceuticals USA, Inc.17$261
E.R. Squibb & Sons, L.L.C.13$251
Corium, LLC19$250
Neurocrine BioSciences, Inc.8$238
Janssen Pharmaceuticals, Inc8$218
Alkermes, Inc.10$179

Products named: CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, COBENFY, Azstarys, INGREZZA, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.